Evidence map›Paper›PMID 34785564›Full record

ArticleBMJ open diabetes research & care2021

Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide.

Noor Suleiman, Meis Alkasem, Shaimaa Hassoun, Ibrahem Abdalhakam, Ilham Bettahi, Fayaz Mir, Manjunath Ramanjaneya, Jayakumar Jerobin, Ahmad Iskandarani, Tareq A Samra and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Noor SuleimanQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Meis AlkasemQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Shaimaa HassounQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Ibrahem AbdalhakamQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Ilham BettahiQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Fayaz MirQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Manjunath RamanjaneyaQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-9765-9818
Jayakumar JerobinQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Ahmad IskandaraniQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Tareq A SamraQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Prem ChandraMedical Research Center, Hamad Medical Corporation, Doha, Qatar.
Monica SkarulisQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar.
Abdul Badi Abou-SamraQatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar ASamra@hamad.qa.
Hamad Medical Corporation · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDecreased insulin sensitivity occurs early in type 2 diabetes (T2D). T2D is highly prevalent in the Middle East and North Africa regions. This study assessed the variations in insulin sensitivity in normal apparently healthy subjects and the levels of adiponectin, adipsin and inflammatory markers. RESEARCH DESIGN AND

methodsA total of 60 participants (aged 18-45, body mass index <28) with a normal oral glucose tolerance test (OGTT) completed hyperinsulinemic-euglycemic clamp (40 mU/m

resultsThe subjects showed wide variations in the whole-body glucose disposal rate (M value) from 2 to 20 mg/kg/min and were divided into three groups: most responsive (M>12 mg/kg/min, n=17), least responsive (M≤6 mg/kg/min, n=14) and intermediate responsive (M=6.1-12 mg/kg/min, n=29). Insulin and C peptide responses to OGTT were highest among the least insulin sensitive group. Triglycerides, cholesterol, alanine transaminase (ALT) and albumin levels were higher in the least responsive group compared with the other groups. Among the inflammatory markers, C reactive protein (CRP) was highest in the least sensitivity group compared with the other groups; however, there were no differences in the level of soluble receptor for advanced glycation end products and Tumor Necrosis Factor Receptor Superfamily 1B (TNFRS1B). Plasma levels of insulin sensitivity markers, adiponectin and adipsin, and oxidative stress markers, oxidized low-density lipoprotein, total antioxidant capacity and glutathione peroxidase 1, were similar between the groups.

conclusionsA wide range in insulin sensitivity and significant differences in triglycerides, cholesterol, ALT and CRP concentrations were observed despite the fact that the study subjects were homogenous in terms of age, gender and ethnic background, and all had normal screening comprehensive chemistry and normal glucose response to OGTT. The striking differences in insulin sensitivity reflect differences in genetic predisposition and/or environmental exposure. The low insulin sensitivity status associated with increased insulin level may represent an early stage of metabolic abnormality.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceArabsC-PeptideHealthy VolunteersHumansInsulinMaleC-PeptideInsulindiabetes mellitusglucose tolerance testhyperinsulinisminsulin resistancetype 2

Identifiers

PMID34785564
PMCPMC8596034
OpenAlexW3213041473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.